Exact Mass: 761.4047

Exact Mass Matches: 761.4047

Found 44 metabolites which its exact mass value is equals to given mass value 761.4047, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(2S)-2-amino-3-[[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H64NO10P (761.4268)

(2S)-2-amino-3-[[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H64NO10P (761.4268)

(2S)-2-amino-3-[[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C41H64NO10P (761.4268)

PC 20:5/13:4;O2

C41H64NO10P (761.4268)

PC 33:9;O2

C41H64NO10P (761.4268)

LNAPS 34:9;O

C40H60NO11P (761.3904)

LNAPS 35:8

C41H64NO10P (761.4268)

PS O-32:4;O3

C38H68NO12P (761.4479)

PS P-20:0/12:3;O3

C38H68NO12P (761.4479)

PS P-20:1/12:2;O3

C38H68NO12P (761.4479)

PS 14:1/18:2;O2

C38H68NO12P (761.4479)

PS 20:0/12:3;O2

C38H68NO12P (761.4479)

PS 20:1/11:3;O3

C37H64NO13P (761.4115)

PS 20:1/12:2;O2

C38H68NO12P (761.4479)

PS 22:6/12:3;O

C40H60NO11P (761.3904)

PS 31:4;O3

C37H64NO13P (761.4115)

PS 32:3;O2

C38H68NO12P (761.4479)

PS 34:9;O

C40H60NO11P (761.3904)

SHexCer 32:4;O3

C38H67NO12S (761.4384)

TFLLR-NH2(TFA)

C33H54F3N9O8 (761.4047)

TFLLR-NH2 (TFA) is a selective PAR1 agonist with an EC50 of 1.9 μM.

(3s,6s,12s,15s,18s,23as)-6,12-bis[(2s)-butan-2-yl]-1,4,7,10,13,16-hexahydroxy-18-(3h-imidazol-4-ylmethyl)-3-(2-methylpropyl)-15-[2-(methylsulfanyl)ethyl]-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-19-one

(3s,6s,12s,15s,18s,23as)-6,12-bis[(2s)-butan-2-yl]-1,4,7,10,13,16-hexahydroxy-18-(3h-imidazol-4-ylmethyl)-3-(2-methylpropyl)-15-[2-(methylsulfanyl)ethyl]-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-19-one

C36H59N9O7S (761.4258)

15-benzyl-1,7-dihydroxy-3-(hydroxymethyl)-6-isopropyl-5,11,12-trimethyl-9-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclooctadecane-4,10,13,16-tetrone

15-benzyl-1,7-dihydroxy-3-(hydroxymethyl)-6-isopropyl-5,11,12-trimethyl-9-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclooctadecane-4,10,13,16-tetrone

C41H55N5O9 (761.4)

2-({2-[(2-{2-[(3-amino-10-chloro-1,2-dihydroxydecylidene)amino]-n-methylpropanamido}-1-hydroxy-4-methylpentylidene)amino]-1-hydroxy-3-(4-hydroxyphenyl)propylidene}amino)-3-(4-hydroxyphenyl)propanoic acid

2-({2-[(2-{2-[(3-amino-10-chloro-1,2-dihydroxydecylidene)amino]-n-methylpropanamido}-1-hydroxy-4-methylpentylidene)amino]-1-hydroxy-3-(4-hydroxyphenyl)propylidene}amino)-3-(4-hydroxyphenyl)propanoic acid

C38H56ClN5O9 (761.3766)

(3s,6s,9s,12s,15r,20as)-15-benzyl-1,7-dihydroxy-3-(hydroxymethyl)-6-isopropyl-5,11,12-trimethyl-9-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclooctadecane-4,10,13,16-tetrone

(3s,6s,9s,12s,15r,20as)-15-benzyl-1,7-dihydroxy-3-(hydroxymethyl)-6-isopropyl-5,11,12-trimethyl-9-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclooctadecane-4,10,13,16-tetrone

C41H55N5O9 (761.4)